﻿                         序列表

<110>  苏州方科生物科技有限公司
       苏州系统医学研究所

<120>  新型冠状病毒特异性抗原肽及其用途

<130>  6A59-2033466IB

<150>  202010318504.3
<151>  2020-04-21

<160>  7

<170>  SIPOSequenceListing 1.0

<210>  1
<211>  15
<212>  PRT
<213>  SARS-CoV-2

<400>  1
Pro Pro Ala Tyr Thr Asn Ser Phe Thr Arg Gly Val Tyr Tyr Pro 
1               5                   10                  15  

<210>  2
<211>  20
<212>  PRT
<213>  SARS-CoV-2

<400>  2
Ala Ser Tyr Gln Thr Gln Thr Asn Ser Pro Arg Arg Ala Arg Ser Val 
1               5                   10                  15      
Ala Ser Gln Ser 
            20  

<210>  3
<211>  15
<212>  PRT
<213>  SARS-CoV-2

<400>  3
Asn Arg Ala Leu Thr Gly Ile Ala Val Glu Gln Asp Lys Asn Thr 
1               5                   10                  15  

<210>  4
<211>  15
<212>  PRT
<213>  SARS-CoV-2

<400>  4
Asn Gly Ile Gly Val Thr Gln Asn Val Leu Tyr Glu Asn Gln Lys 
1               5                   10                  15  

<210>  5
<211>  15
<212>  PRT
<213>  SARS-CoV-2

<400>  5
Tyr Phe Lys Asn His Thr Ser Pro Asp Val Asp Leu Gly Asp Ile 
1               5                   10                  15  

<210>  6
<211>  15
<212>  PRT
<213>  SARS-CoV-2

<400>  6
Ile Asp Leu Gln Glu Leu Gly Lys Tyr Glu Gln Tyr Ile Lys Trp 
1               5                   10                  15  

<210>  7
<211>  15
<212>  PRT
<213>  SARS-CoV-2

<400>  7
Asp Glu Asp Asp Ser Glu Pro Val Leu Lys Gly Val Lys Leu His 
1               5                   10                  15  

